Constitutive expression of Bcl-3 in thymocytes increases the DNA binding of NF-κB1 (p50) homodimers in vivo

Molecular and Cellular Biology

Volumn 16, Issue 4, 1996, Pages 1342-1348

  Caamaño, Jorge H ^a   Perez, Paloma ^a   Lira, Sergio A ^a   Bravo, Rodrigo ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; DNA; ONCOPROTEIN; PROTO ONCOGENE PROTEIN BCL 3; PROTO-ONCOGENE PROTEIN BCL-3; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; BINDING SITE; DEPHOSPHORYLATION; DNA BINDING; GENE EXPRESSION; GENE EXPRESSION REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; THYMOCYTE; TRANSGENIC MOUSE; ANIMAL; CELL CULTURE; CYTOLOGY; FLOW CYTOMETRY; METABOLISM; MOUSE; NUCLEOTIDE REPEAT; PHOSPHORYLATION; THYMUS; TRANSACTIVATION; WESTERN BLOTTING;

ANIMALS; ANKYRINS; BLOTTING, WESTERN; CELLS, CULTURED; DNA; FLOW CYTOMETRY; MICE; MICE, TRANSGENIC; NF-KAPPA B; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; REPETITIVE SEQUENCES, NUCLEIC ACID; THYMUS GLAND; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 0029665444     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.4.1342     Document Type: Article

References (65)

1. Adams, J. M., and S. Cory. 1991 Transgenic models of tumor development. Science 254:1161-1167.
2. Alkalay, I., A. Yaron, A. Hatzubai, S. Jung, A. Avraham, O. Gerlitz, I. Pashut-Lavon, and Y. Ben-Neriah. 1995 In vivo stimulation of IκB phosphorylation is not sufficient to activate NF-κB. Mol. Cell. Biol. 15:1294-1301.
3. Allen, J. M., K. A. Forbush, and R. M. Perlmutter. 1992. Functional dissection of the lck proximal promoter. Mol. Cell. Biol 12:2758-2768.
4. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu Rev Immunol. 12:141-179.
5. Beg, A. A., and A. S. Baldwin, Jr. 1993. The IκB proteins, multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev. 7:2064-2070.
6. Beg, A. A., S. M. Ruben, R. I. Scheinman, S. Haskill, C. A. Rosen, and A. S. Baldwin, Jr. 1992. IκB interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention. Genes Dev. 6:1899-1913.
7. Beg, A. A., W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component NF-κD. Nature (London) 376:167-169.
8. Bhatia, K., K. Huppi, T. McKeithan, D. Siwarski, J. Mushinski, and I. M. Magrath. 1991. Mouse bel-3: cDNA structure, mapping and stage-dependent expression in B lymphocytes. Oncogene 6:1569-1573
9. Bours, V., G. Franzoso, V. Azarenko, S. Park, T. Kanno, K. Brown, and U. Siebenlist. 1993. The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-bindmg p50B homodimers. Cell 72:729-739
10. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science 267:1485-1488.
11. Burkly, L., C. Hesslon, L. Ogata, C. Reilly, L. A. Marconi, D. Olson, R. Tizard, R. Cate, and D. Lo. 1995. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature (London) 373: 531-536.
12. Caamaño, J., and R. Bravo. Unpublished data.
13. Carrasco, D., R.-P. Ryseck, and R. Bravo. 1993. Expression of relB transcripts during lymphoid organ development: specific expression in dendritic antigen-presenting cells. Development 118:1221-1231.
14. Carrasco, D., F. Weih, and R. Bravo. 1994 Developmental expression of the mouse c-rel protooncogene in hematopoietic organs Development 120:2991-3004
15. Chaffin, K. E., C. R. Beals, T. M. Wilkie, K. A. Forbush, M. I. Simon, and R. M. Perlmutter. 1990. Dissection of thymocyte signaling pathways by in vivo expression of pertussis toxin ADP-ribosyltransferase EMBO J. 9:3821-3829.
16. Coligan, J. E., A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober. 1992. Isolation and fractionation of mononuclear cell populations. Greene Publishing Associates and Wiley-Interscience, New York.
17. Collart, M. A., P. Baeuerle, and P. Vassalli. 1990. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB. Mol Cell Biol. 10:1498-1506
18. DiDonato, J. A., F. Mercurio, and M. Karin. 1995. Phosphorylation of IκBα precedes but is not sufficient for its dissociation from NF-κB. Mol. Cell. Biol 15:1302-1311.
19. Finco, T. S., A. A. Beg, and A. S. Baldwin, Jr. 1994. Inducible phosphorylation of IκBα is not sufficient for its dissociation from NF-κB and is inhibited by protease inhibitors. Proc. Natl. Acad. Sci. USA 91:11884-11888
20. Franzoso, G., V. Bours, V. Azarenko, S. Park, M. Tomita-Yamaguchi, T. Kanno, K. Brown, and U. Siebenlist. 1993. The oncoprotein Bcl-3 can facilitate NF-κB-mediated transactivation by removing inhibiting p50 homodimers from select κB sites EMBO J. 12:3893-3901
21. Franzoso, G., V. Bours, S. Park, M. Tomita-Yamaguchi, K. Kelly, and U. Siebenlist. 1992 The candidate oncoprotein Bcl-3 is an antagonist of p50NF-κB-mediated inhibition. Nature (London) 359:339-342.
22. Fujita, T., G. P. Nolan, S. Ghosh, and D. Baltimore. 1992. Independent modes of transcriptional activation by the p50 and p65 subunits of NF-κB. Genes Dev. 6:775-787.
23. Fujita, T., G. P. Nolan, H.-C. Liou, M. L. Scott, and U. Baltimore. 1993. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-κB p50 homodimers. Genes Dev 7:1354-1363.
24. Gilmore, T. D., and P. J. Morin. 1993. The IκB proteins: members of a multifunctional family Trends Genet. 9:427-433.
25. Harlow, E., and D. Lane (ed.). 1988 Antibodies, a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y
26. Hatada, E. N., A. Nieters, F. G. Wulczyn, M. Naumann, R. Meyer, G. Nucifora, T. W. McKeithan, and C. Scheidereit. 1992. The ankyrin repeat domains of the NF-κB precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-κB DNA binding. Proc. Natl. Acad. Sci USA 89:2489-2493.
27. Inoue, J.-I., T. Takahara, T. Akizawa, and O. Hino, 1993. Bcl-3, a member of the IκB proteins, has distinct specificity towards the Rel family of proteins. Oncogene 8:2067-2073.
28. Kang, S.-M., A.-C. Tran, M. Grilli, and M. J. Lenardo. 1992 NF-κB subunit regulation in nontransformed CD4+ T lymphocytes. Science 256:1452-1456.
29. Kennelly, P. J., and E. G. Krebs. 1991. Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases. J Biol. Chem. 266:15555-15558.
30. Kontgen, F., R. J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlinton, and S. Gerondakis. 1995 Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9:1965-1977.
31. Kretzschmar, M., M. Meisterernst, C. Scheidereit, G. Li, and R. G. Roeder. 1992 Transcriptional regulation of the HIV-1 promoter by NF-κB in vitro. Genes Dev. 6:761-774.
32. Lenardo, M., and U. Siebenlist. 1994 Bcl-3-mediated nuclear regulation of the NF-κB trans-activating factor. Immunol. Today 15:145-147
33. Lernbecher, T., U. Muller, and T. Wirth. 1993 Distinct NF-κB/Rel transcription factors are responsible for tissue-specific and inducible gene activation Nature (London) 365:767-770.
34. Leveillard, T., and I. M. Verma. 1993. Diverse molecular mechanisms of inhibition of NF-κB/DNA binding complexes by IκB proteins. Gene Exp. 3:135-150.
35. Li, C.-C. H., R.-M. Dai, E. Chen, and D. L. Longo. 1994. Phosphorylation of NF-KB1-p50 is involved in NF-κB activation and stable DNA binding J. Biol. Chem 269:30089-30092.
36. Lin, Y.-Z., S. Yao, R. A. Veach, T. R. Torgerson, and J. Hawiger. 1995. Inhibition of nuclear translocation of transcription factor NF-κB by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem. 270:14255-14258.
37. Liou, H.-C., and D. Baltimore. 1993. Regulation of the NF-κB/rel transcription factor and κB inhibitor system. Curr. Opin. Cell Biol. 5:477-487.
38. Mann, J. R., and A. P. McMahon. 1993. Factors influencing frequency production of transgenic mice. Methods Enzymol. 225:771-781.
39. McKeithan, T. W., H. Ohno, and M. O. Diaz. 1989. Identification of a tianscriplional unit adjacent to the breakpoint in the 14;19 translocation of chronic lymphocytic leukemia. Genes Chromosomes Cancer 1:247-255.
40. McKeithan, T. W., J. D. Rowley, T. B. Shows, and M. O. Diaz. 1987. Cloning of the chromosome translocation breakpoint junction of the t(14;19) in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci USA 84:9257-9260.
41. Miyamoto, S., M. Maki, M. J. Schmitt, M. Hatanaka, and I. M. Verma. 1994. Tumor necrosis factor α-induced phosphorylation of IκBα is a signal for its degradation but not dissociation from NF-κB. Proc. Natl. Acad. Sci. USA 91:12740-12744.
42. Naumann, M., F. G. Wulczyn, and C. Scheidereit. 1993. The NF-κB precursor p105 and the proto-oncogene product Bcl-3 are IκB molecules and control nuclear translocation of NF-κB. EMBO J. 12:213-222.
43. Nulan, G. P., T. Fujita, K. Bhatia, C. Huppi, H.-C. Liou, M. L. Scott, and D. Baltimore. 1993. The bcl-3 proto-oncogene encodes a nuclear IκB-like molecule that preferentially interacts with NF-κB p50 and p52 in a phosphorylation-dependent manner. Mol. Cell. Biol. 13:3557-3566
44. Ohno, H., S. Doi, K. Yabumoto, S. Fukuhara, and T. W. McKeithan. 1993. Molecular characterization of the t(14;19)(q32;q13) translocation in chronic lymphocytic leukemia. Leukemia (Baltimore) 7:2057-2063.
45. Ohno, H., G. Takimoto, and T. W. McKeithan. 1990. The candidate protooncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell 60:991-997
46. Perez, P., S. A. Lira, and R. Bravo. 1995. Overexpression of RelA in transgenic mouse thymocytes, specific increase in levels of the inhibitor protein IκBα. Mol. Cell Biol. 15:3523-3530.
47. b gene expression in metastatic tumor cells J Exp. Med. 177:1651-1662.
48. Robb, L., J. E. J. Rasko, M. L. Bath, A. Strasser, and C. G. Begley. 1995. scl, a gene frequently activated in human T cell leukaemia, does not induce lymphomas in transgenic mice. Oncogene 10:205-209.
49. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
50. Scbmitz, M. L., and P. A. Baeuerle. 1991. The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J. 10:3805-3817.
51. Schouten, G. J., A. J. van der Eb, and A. Zantema. 1995. Downregulation of MHC class 1 expression due to interference with p105-NF-κB1 processing by AD12E1A. EMBO J. 14:1498-1507.
52. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with "mini-extracts", prepared from a small number of cells. Nucleic Acids Res. 17:6419.
53. Sha, W. C., H.-C. Liou, E. I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80:321-330.
54. Siebenlist, U., G. Franzoso, and K. Brown. 1994 Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10:405-455.
55. Ten, R. M., C. V. Paya, N. Israel, O. Le Bail, M.-G. Mattei, J.-L. Virelizier, P. Kourilsky, and A. Israel. 1992. The characterization of the promoter of the gene encoding the p50 subunit of NF-κB indicates that it participates in its own regulation. EMBO J 11:195-203.
56. Thanos, D., and T. Maniatis. 1995. NF-κB: a lesson in family values. Cell 80:529-532.
57. Thompson, J. E., R. J. Phillips, H. Erdjument-Bromage, P. Tempst, and S. Ghosh. 1995. IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell 80:573-582.
58. Traenckner, E. B.-T., H. L. Pahl, T. Henkel, K. N. Schmidt, S. Wilk, and P. A. Baeuerle. 1995. Phosphorylation of human IκBα on serines 32 and 36 controls IκBα proteolysis and NF-κB activation in response to diverse stimuli. EMBO J 14:2876-2883.
59. Traenckner, E. B.-T., S. Wilk, and P. A. Baeuerle. 1994. A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB. EMBO J. 13:5433-5441.
60. Ueshima, Y., M. L. Bird, J. W. Vardiman, and J. D. Rowley. 1985. A 14;19 translocation in B-cell chronic leukemia: a new recurring chromosome aberration. Int J Cancer 36:287-290.
61. van't Veer, L. J., R. L. Beijersbergen, and R. Bernards. 1993. N-myc suppresses major histocompatibility complex class 1 gene expression through down-regulation of the p50 subunit of NF-κB. EMBO J. 12:195-200.
62. Weih, F., D. Carrasco, and R. Bravo. 1994. Constitutive and inducible Rel/ NF-κB activities in mouse thymus and spleen. Oncogene 9:3289-3297
63. Weih, F., D. Carrasco, S. K. Durham, D. S. Barton, C. A. Rizzo, R.-P. Ryseck, S. Lira, and R. Bravo. 1995 Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the Rel/NF-κB family Cell 80:331-340.
64. Wulczyn, F. G., M. Naumann, and C. Scheidereit. 1992 Candidate protooncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-κB. Nature (London) 358:597-599.
65. Yabumoto, K., H. Ohno, S. Doi, S. Edamura, Y. Arita, T. Akasaka, J. Matsumoto, N. Kadowaki, S. Fukuhara, and M. Okuma. 1994. Involvement of the BCL3 gene in two patients with chronic lymphocytic leukemia. Int. J. Hematol. 59:211-218